Press release
Cardiac Marker Testing Market to reach up to USD 10.5 billion by 2031 | Siemens Healthineers AG, Danaher Corporation, bioMérieux SA
Cardiac markers are utilized in the treatment and risk stratification of patients with the suspected coronary acute syndrome (ACS). Troponin I and T, HDCRP, myoglobin, CK-MB, and other cardiac marker tests are among the most common. When the heart is stressed or injured, substances called cardiac markers are released into the blood. Hormones, enzymes, and proteins are examples of these markers. These biomarkers can be helpful to detect a variety of heart disorders, comprising acute coronary syndrome, cardiac ischemia, and conditions involving obstructed blood flow to the heart. Physicians perform several cardiac marker tests over several hours to keep track of the blood sugar increase and determine the severity of a heart attack.
Request free sample copy of this research study: https://www.globalinsightservices.com/request-sample/GIS10254
Market Trends and Drivers
The key factor boosting the growth of the market is the growing incidence of cardiovascular diseases. The prevalence of lifestyle diseases such as hypertension, obesity, dyslipidemia, and diabetes, which are major risk factors for CVD, is also on the rise. In 2016, more than 1.9 billion adults globally were overweight; of these, over 600 million people were obese. It is anticipated that ~41% of the world's population will be overweight or obese by 2030. The association between obesity and the risk of coronary heart disease was published by investigators (Bogers RP, Bemelmans WJ, Hogeveen RT, et al.) by a meta-analysis of 21 long-term studies conducted by them with more than 300,000 participants. It was witnessed that participants who were overweight had a 32% higher risk of developing coronary artery disease (CAD), and those who were obese had an 81% higher risk as compared with participants who were a normal weight.
Read more about Cardiac Marker Testing Market here: https://www.globalinsightservices.com/reports/cardiac-marker-testing-market/
Market Segments
By Product
Reagents & Kits
Instruments
By Biomarker Type
Troponin I and T
CK-MB
Bnp or Nt-Probnp
Hscrp
Others
By Disease
Myocardial Infarction
Congestive Heart Failure
Acute Coronary Syndrome
Atherosclerosis
Ischemia
Get Customized Report as Per Your Requirement: https://www.globalinsightservices.com/request-customization/GIS10254
Major Players in Global Cardiac Marker Testing Market
The key players in the global cardiac marker testing market are Roche Diagnostics Ltd. (Switzerland), Abbott Laboratories (US), Siemens Healthineers AG (Germany), Danaher Corporation (US), bioMérieux SA (France), LSI Medience Corporation (Japan), Ortho Clinical Diagnostics (US), Randox laboratories Ltd. (UK), Guangzhou Wondfo Biotech Co., Ltd (China), DiaSorin S.p.A. (Italy), Becton, Dickinson and Company (US), Bio-Rad Laboratories, Inc. (US), PerkinElmer Inc. (US), Thermo Fisher Scientific Inc. (US), Tosoh Corporation (Japan).
Purchase your copy now: https://www.globalinsightservices.com/checkout/single_user/GIS10254
With Global Insight Services, you receive:
• 10-year forecast to help you make strategic decisions
• In-depth segmentation which can be customized as per your requirements
• Free consultation with lead analyst of the report
• Excel data pack included with all report purchases
• Robust and transparent research methodology
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cardiac Marker Testing Market to reach up to USD 10.5 billion by 2031 | Siemens Healthineers AG, Danaher Corporation, bioMérieux SA here
News-ID: 3207414 • Views: …
More Releases from Global Insight Services
Liver Disease Treatment Market: Expansion Fueled by Increasing Incidence of NAFL …
The Liver Disease Treatment Market continues to expand rapidly as global awareness, early diagnosis, and advanced therapeutic approaches reshape patient care. With the market valued at $26.6 billion in 2024 and projected to reach $44.8 billion by 2034 at a steady 5.4% CAGR, demand for effective and accessible therapies is on the rise. The Liver Disease Treatment Market covers pharmaceuticals, biologics, vaccines, diagnostics, and liver transplant services designed to manage…
Healthcare Supply Chain BPO Market: Expansion Fueled by Increasing Outsourcing o …
The Healthcare Supply Chain BPO Market is rapidly evolving as healthcare providers worldwide seek smarter, leaner, and more resilient operations. With growing pressure to reduce costs, boost efficiency, and maintain uninterrupted patient care, outsourcing supply chain tasks has become a strategic necessity. The global Healthcare Supply Chain BPO Market is projected to grow from $3.05 billion in 2024 to $4.83 billion by 2034, reflecting a CAGR of 4.7%. This expansion…
Robotics Crawler Camera System Market Rise by 2034 | Key Players: Inuktun Servic …
Market Overview
Robotics Crawler Camera System Market is witnessing a major transformation as industries shift toward advanced inspection technologies that improve safety, accuracy, and operational efficiency. These robotic crawlers, equipped with high-resolution cameras and strong maneuverability, enable real-time inspection across pipelines, sewers, industrial tanks, and hazardous environments where manual inspections pose risks. As automation becomes central to industrial maintenance, the Robotics Crawler Camera System Market continues to gain momentum, supported by…
Pet DNA Testing Market Growth to 2034 | Key Players: Wisdom Panel, Embark Veteri …
Market Overview
Pet DNA Testing Market is rapidly transforming the way pet owners understand the health, ancestry, and traits of their companion animals. As pets increasingly become family members, owners are demanding deeper insights into their pets' genetic makeup. The Pet DNA Testing Market offers services such as breed identification, disease risk assessments, trait analysis, and ancestry mapping. With advancements in genomics and the expansion of direct-to-consumer testing kits, the Pet…
More Releases for Cardiac
Cardiac Resynchronization Therapy: Driving Innovation and Transforming Global Ca …
London, UK - August 2025 | Strategic Revenue Insights Inc. The global cardiac resynchronization therapy (CRT) market is emerging as one of the most crucial sectors in cardiovascular healthcare, offering life-saving solutions for patients with heart failure and conduction abnormalities. CRT devices, including pacemakers and defibrillators, are designed to restore synchronized heart contractions, significantly improving patient survival rates and quality of life. With rising cardiovascular disease prevalence worldwide, CRT has…
Mobile Cardiac Telemetry Systems Market Redefining Remote Cardiac Monitoring
"In recent years, the global Mobile Cardiac Telemetry Systems Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Mobile Cardiac Telemetry Systems Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot…
Ambulatory Cardiac Monitoring Devices Market: Revolutionizing Cardiac Care
In the rapidly evolving landscape of healthcare, the Ambulatory Cardiac Monitoring Devices Market stands out as a beacon of innovation and progress. These devices, including ECG devices, Holter monitors, event monitors, implantable loop recorders, and mobile cardiac telemetry, have become indispensable tools for healthcare professionals in managing and diagnosing cardiac conditions. As heart-related issues continue to afflict millions globally, the demand for advanced cardiac monitoring solutions is on the rise.
Request…
Cardiac Monitoring & Cardiac Rhythm Management Devices Market - Precision Monito …
Newark, New Castle, USA: The "Cardiac Monitoring & Cardiac Rhythm Management Devices Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Cardiac Monitoring & Cardiac Rhythm Management Devices…
Cardiac Monitoring & Cardiac Rhythm Management Device Market
According to a new market research report published by Global Market Estimates, the Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market is expected to grow at a CAGR of 3.88% during the forecast period. The increasing occurrence of dyslipidemia, hypertension, and rising demand for cardiac monitoring & cardiac rhythm management devices to save patients at a huge risk of cardiac arrest.
Browse 145 Market Data Tables and 119 Figures spread…
Global Cardiac Monitoring & Cardiac Rhythm Management Market Insights, Forecast
Cardiac monitoring (CM) devices help in continuous examination of a patient’s cardiac activity. Cardiac rhythm management (CRM) devices maintain normal cardiac rhythm in patients suffering from rate and rhythm disorders of the heart. These devices play a crucial role in the treatment of serious cardiac disorders, including heart failure, atrial fibrillation, atrial flutter, indications of recent heart attack, coronary ischemia, lack of oxygen supply to cardiac muscles, effects of drugs,…
